Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 51
Page 51 of 114 · 1029 articles
State False Claims Acts and Parallel Recoveries
State False Claims Acts let attorneys general pursue Medicaid fraud independent of DOJ, creating exposure a federal settlement alo…
Consent Orders: Reading the Long-Term Consequences
A signed consent order triggers a permanent NPDB report, payer credentialing disclosures, and possible OIG exclusion long after th…
Building a Wound Care Compliance Program
Chart auditing cadence, coding review, and remediation records are what turn a self-identified billing error into a correction ins…
UPIC Audits and Your Medicare Enrollment Status
UPIC audit findings can trigger Medicare payment suspension, deactivation, or revocation, with a reenrollment bar that runs for ye…
UPIC Audits of Pharmacies Under Part D
UPICs review Part B and Medicaid pharmacy claims, not Part D. Here is how the two audit tracks overlap through prescriber pattern…
PPP Loan Fraud Enforcement Against Healthcare Practices
Certification exposure on 2020 PPP loans stays live through 2030. Recent DOJ judgments against healthcare businesses turn on a sig…
Patient Recruiting and Marketing Arrangements
Percentage-based marketing fees and patient recruiting arrangements can trigger Anti-Kickback Statute and False Claims Act exposur…
Wound Care LCD Compliance Across MAC Jurisdictions
CMS nationalized the skin substitute payment rate for 2026, but coverage still depends on which Medicare Administrative Contractor…
Stark Law Violations Feeding False Claims Liability
A Stark Law self-referral violation needs no intent, and billing Medicare for the referred service can turn it into False Claims A…